A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
Status:
Completed
Trial end date:
2020-11-27
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetics similarity between the liraglutide injection (RD12014)
produced by Sunshine Lake Pharma Co., Ltd. and liraglutide injection (Victoza®) produced by
Novo Nordisk Pharmaceutical Co., Ltd for single dose in healthy male subjects, as well as to
evaluate the similarity of the safety and immunogenicity between RD12014 and Victoza ® in
healthy subjects.